Dr. Seyedqumars Mirfendereski, MD
- Medicare services, 2024
- 1,946
- Medicare patients, 2024
- 616
- Part D claims, 2024
- 696
- Hospital affiliations
- 5
- Industry payments
- $3,071
- Practice address
- 2250 South Rancho Drive, Ste 115, Las Vegas, NV 89102
- Practice phone
- Call (702) 795-1771
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
DaVita South Las Vegas Dialysis Center
Dialysis Center - Independent · Las Vegas, Nevada
Find Dr. Mirfendereski's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Seyedqumars Mirfendereski is a nephrologist in Las Vegas, Nevada
Dr. Mirfendereski practices at DaVita South Las Vegas Dialysis Center in Las Vegas, Nevada.
Dr. Mirfendereski's NPI, 1558555680, was assigned on August 31, 2007. Dr. Mirfendereski holds Nevada license 13597.
- NPI
- 1558555680NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8527139815
- NPI enumeration date
- August 31, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (702) 795-1771
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Seyedqumars Mirfendereski practices at DaVita South Las Vegas Dialysis Center in Las Vegas, Nevada
Dr. Mirfendereski's primary practice is DaVita South Las Vegas Dialysis Center, at 2250 South Rancho Drive, Ste 115, Las Vegas, NV 89102 in Clark County. The practice phone is (702) 795-1771.
- DaVita South Las Vegas Dialysis Center2250 South Rancho Drive, Ste 115, Las Vegas, NV 89102 · Clark CountyPhone(702) 795-1771
Source: Dmand AI Affiliation Data
Dr. Seyedqumars Mirfendereski is affiliated with 7 sites of care and 1 medical group
Dr. Mirfendereski's primary practice is DaVita South Las Vegas Dialysis Center in Las Vegas, Nevada. Dr. Mirfendereski is also affiliated with Sunrise Hospital and Medical Center. The medical group on file is Kidney Specialists of Southern Nevada. Dmand AI also links Dr. Mirfendereski to 4 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Seyedqumars Mirfendereski's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirfendereski practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| DaVita South Las Vegas Dialysis Center | Available with a free account |
| +6 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Seyedqumars Mirfendereski is one of 120 nephrologists in Nevada
Nephrology is Dr. Mirfendereski's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mirfendereski is licensed in Nevada.
Specialties and state licenses
- Nephrology, NevadaPrimary
Nephrologists near Dr. Mirfendereski
Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Seyedqumars Mirfendereski billed Medicare for 1,946 services in 2024
CMS data shows 1,946 Medicare services from Dr. Mirfendereski across 10 procedure codes in 2024, for 616 Medicare patients. Medicare paid $160,777 for them.
Dr. Mirfendereski's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,4662024: 1,5778%
- Other services
- 2023: 02024: 273
- Tests and treatments
- 2023: 1442024: 9633%
Where Dr. Mirfendereski's Medicare services took place, 2024
- In an office69236%
- In a facility1,25464%
Dr. Mirfendereski compared with the Nevada median for nephrologists, 2024
- Dr. Mirfendereski
- Nevada median
- Medicare services
- 1,946vs 1,42437% above
- Medicare patients
- 616vs 38162% above
- Part D claims
- 537vs 558Close to median
Medians across 116 nephrologists in Nevada with Dmand AI profiles that report each measure.
Dr. Mirfendereski's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mirfendereski?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mirfendereski and other nephrologists in Nevada.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Seyedqumars Mirfendereski treated 616 Medicare patients in 2024, average age 74
CMS counts 616 Medicare patients who saw Dr. Mirfendereski in 2024. The largest group is 75 to 84, with 235 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 3.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mirfendereski's median patient age at 68, with 44% women.
Dr. Mirfendereski's Medicare patients by age, 2024
Dr. Mirfendereski's Medicare patients by sex, 2024
- Women32853%
- Men28847%
Chronic conditions among Dr. Mirfendereski's Medicare patients, 2024
- Chronic kidney disease75%
- High blood pressure75%
- High cholesterol75%
- Diabetes62%
- Ischemic heart disease56%
- Heart failure51%
- Arthritis49%
- Anxiety37%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mirfendereski's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women44%
- Men55%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Seyedqumars Mirfendereski wrote 696 Medicare Part D claims in 2024
In 2024, Dr. Mirfendereski wrote 696 Medicare Part D claims for 139 patients. 88% of them were for generic drugs. CMS names the drug for 537 of them, across 15 drugs with 11 or more claims each, at $36,627 in total drug cost. In 2023, CMS named 477 claims across 14 drugs.
Dr. Mirfendereski's Part D claims by kind of drug, 2024
- Generic611 claims88%
- Brand-name and other85 claims12%
Dr. Mirfendereski's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mirfendereski's Part D claims, 2024
- Antibiotics3%21 of 696 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4772024: 53713%
Drugs named by CMS: 15 in 2024, 14 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Seyedqumars Mirfendereski offers telehealth to Medicare patients
Dr. Mirfendereski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mirfendereski as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Seyedqumars Mirfendereski received $3,071 in industry payments from 2016 to 2025
CMS Open Payments shows 124 general payments to Dr. Mirfendereski from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $429.
General payments to Dr. Mirfendereski by program year, 2016 to 2025
Companies that paid Dr. Mirfendereski the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Seyedqumars Mirfendereski's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Seyedqumars Mirfendereski
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Seyedqumars Mirfendereski's NPI number?
Dr. Seyedqumars Mirfendereski's NPI number is 1558555680. It was assigned on August 31, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Seyedqumars Mirfendereski?
Dr. Seyedqumars Mirfendereski is a nephrologist in Las Vegas, Nevada. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).
Where does Dr. Seyedqumars Mirfendereski practice?
Dr. Mirfendereski practices at 2250 South Rancho Drive, Ste 115, Las Vegas, NV 89102. Dr. Mirfendereski's primary practice is DaVita South Las Vegas Dialysis Center in Las Vegas, Nevada. Dmand AI also links Dr. Mirfendereski to 4 hospitals and 1 group practice or clinic.
What is Dr. Seyedqumars Mirfendereski's office phone number?
The practice phone on file for Dr. Mirfendereski is (702) 795-1771.
What is Dr. Seyedqumars Mirfendereski's medical license number?
Dr. Mirfendereski holds Nevada license 13597.
Which hospitals is Dr. Seyedqumars Mirfendereski affiliated with?
Dr. Mirfendereski is affiliated with Sunrise Hospital and Medical Center. Dmand AI links Dr. Mirfendereski to 4 more hospitals.
What medical group is Dr. Seyedqumars Mirfendereski part of?
Dr. Mirfendereski is linked to Kidney Specialists of Southern Nevada.
Does Dr. Seyedqumars Mirfendereski accept Medicare?
Yes. CMS data shows Dr. Mirfendereski billed Medicare for 1,946 services in 2024, and Dr. Mirfendereski accepts Medicare assignment.
Does Dr. Seyedqumars Mirfendereski offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mirfendereski as offering telehealth services.
How many Medicare patients does Dr. Seyedqumars Mirfendereski see?
CMS counts 616 Medicare patients who saw Dr. Mirfendereski in 2024, with an average age of 74.
Show 4 more questionsShow fewer questions
What services does Dr. Seyedqumars Mirfendereski bill to Medicare?
In 2024, Dr. Mirfendereski's most billed Medicare services were hospital inpatient care (99233), hospital inpatient care (99232) and medicare service (G2211).
What drugs does Dr. Seyedqumars Mirfendereski prescribe most?
In 2024 Medicare Part D data, Dr. Mirfendereski's most prescribed drugs by claims were Calcitriol, Amlodipine Besylate and Losartan Potassium.
Has Dr. Seyedqumars Mirfendereski received payments from drug or device companies?
CMS Open Payments shows $3,071 in general payments to Dr. Mirfendereski from 24 companies from 2016 to 2025. The largest total came from GlaxoSmithKline, LLC.
How long has Dr. Seyedqumars Mirfendereski been practicing?
Dr. Mirfendereski graduated from medical school in 1996, 30 years ago.
Selling to nephrology practices?
See nephrologists in Nevada by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card